Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors
Abstract
Two functional types of nicotinic acetylcholine receptors (nAChRs) are expressed when human embryonic kidney cells are permanently transfected with equal amounts of human alpha4 and beta2 subunit cDNAs. Most (82%) of these nAChRs exhibit an EC(50) of 74 +/- 6 microM for ACh, a much lower sensitivity than the remaining fraction (EC(50) of 0.7 +/- 0.4 microM) or than expected from expression of equal amounts of alpha4 and beta2 mRNAs in Xenopus laevis oocytes. We have found three conditions that can increase the number of nAChRs with high sensitivity to activation. These are: 1) transient transfection with additional beta2 subunits, 2) overnight incubation in nicotine, or 3) overnight culture at 29 degrees C. Using metabolic labeling with [(35)S]methionine to measure subunit stoichiometry, we found that the majority of nAChRs had a stoichiometry of (alpha4)(3)(beta2)(2). Overnight treatment with nicotine increased the number of nAChRs and increased the proportion of the (alpha4)(2)(beta2)(3) stoichiometry. Alternate alpha4beta2 nAChR stoichiometries with distinct functional properties raise the possibility for an interesting mode of synaptic regulation for nicotinic signaling in the mammalian brain.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Nicotine causes the preferential assembly of receptors with (α4)2(β2)3 stoichiometry.
“Data from such favorable systems show that nicotine enhances the assembly of functional nAChRs containing the α4 and β2 subunits and also causes the preferential assembly of receptors with (α4)2(β2)3 stoichiometry (Buisson and Bertrand, 2001; Nelson et al., 2003; Kuryatov et al., 2005; Sallette et al., 2005; Vallejo et al., 2005; Son et al., 2009).”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Nelson et al., 2003
Nicotine enhances the assembly of functional nAChRs containing the α4 and β2 subunits.
“Data from such favorable systems show that nicotine enhances the assembly of functional nAChRs containing the α4 and β2 subunits and also causes the preferential assembly of receptors with (α4)2(β2)3 stoichiometry (Buisson and Bertrand, 2001; Nelson et al., 2003; Kuryatov et al., 2005; Sallette et al., 2005; Vallejo et al., 2005; Son et al., 2009).”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Nelson et al., 2003
Nicotine is thought to increase the assembly of receptors with a (α4)2(β2)3 stoichiometry.
“Because nicotine is thought to increase the assembly of receptors with a (α4)2(β2)3 stoichiometry (Nelson et al., 2003; Son et al., 2009)”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Nelson et al., 2003
Chronic nicotine exposure shifts nAChR stoichiometry from approximately equal contributions of the two stoichiometries in nicotine-naive cells to ∼100% (α4)2(β2)3.
“In fact, our experiments and previous data (Buisson and Bertrand, 2001; Nelson et al., 2003; Kuryatov et al., 2005; Sallette et al., 2005; Vallejo et al., 2005; Son et al., 2009) suggest a shift from approximately equal contributions of the two stoichiometries in nicotine-naive cells to ∼100% (α4)2(β2)3 after chronic nicotine exposure.”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Nelson et al., 2003
Previous results based on glycosylation and molecular weight measures show that up-regulation is initiated in the ER.
“These data correspond with previous results based on glycosylation and molecular weight measures, showing that up-regulation is initiated in the ER (Nelson et al., 2003; Kuryatov et al., 2005; Sallette et al., 2005).”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Nelson et al., 2003
The thermodynamic driving force for the stoichiometry shift is the tighter binding of nicotine to the (α4)2(β2)3 stoichiometry.
“The thermodynamic driving force for this stoichiometry shift is presumably the tighter binding of nicotine to the (α4)2(β2)3 stoichiometry (Nelson et al., 2003).”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Nelson et al., 2003
Several studies suggest that the high- and low-sensitivity forms of α4β2 receptors differ in subunit composition: the high- and low-sensitivity forms would consist of the (α4)2(β2)3 and (α4)3(β2)2 pentamers, respectively.
“Several studies suggest that the two forms differ in subunit composition: the high- and low-sensitivity forms would consist of the (α4)2(β2)3 and (α4)3(β2)2 pentamers, respectively (74–76).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [76]
Cites
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · see citing works
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308 · see citing works
Induction, assembly, maturation and maintenance of a postsynaptic apparatus
Sanes, J. R., & Lichtman, J. W. (2001) · Nature reviews. Neuroscience · doi:10.1038/35097557 · Cited by 1,025 · see citing works
An adaptive coding model of neural function in prefrontal cortex
Duncan, J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35097575 · Cited by 874 · see citing works
An adaptive coding model of neural function in prefrontal cortex
Duncan, J. (2001) · UCL Discovery (University College London) · Cited by 738 · see citing works
Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins
Karlin, A., & Akabas, M. H. (1995) · Neuron · doi:10.1016/0896-6273(95)90004-7 · Cited by 622 · see citing works
Benwell, M. E. M., Balfour, D. J. K., & Anderson, J. M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10600.x · Cited by 551 · see citing works
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
Marks, M., Pauly, Jr., Gross, S., Deneris, E., Hermans-Borgmeyer, I., Heinemann, S., & Collins, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02765.1992 · Cited by 551 · see citing works
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
Marubio, L. M., Jiménez, M. D. M. A., Cordero‐Erausquin, M., Léna, C., Novère, N. G. L., d’Exaerde, A. D. K., Huchet, M., Damaj, M. I., & Changeux, J. (1999) · Nature · doi:10.1038/19756 · Cited by 542 · see citing works
Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor
Cooper, E., Couturier, S., & Ballivet, M. (1991) · Nature · doi:10.1038/350235a0 · Cited by 470 · see citing works
Phosphorylation of the nicotinic acetylcholine receptor regulates its rate of desensitization
Huganir, R. L., Delcour, A. H., Greengard, P., & Hess, G. P. (1986) · Nature · doi:10.1038/321774a0 · Cited by 419 · see citing works
Overview of nicotinic receptors and their roles in the central nervous system
Dani, J. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01011-8 · Cited by 414 · see citing works
Chavez-Noriega, L. E., Crona, J. H., Washburn, M. S., Urrutia, A., Elliott, K. J., & Johnson, E. C. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36376-1 · Cited by 405 · see citing works
Chavez-Noriega, L. E., Crona, J. H., Washburn, M. S., Urrutia, A., Elliott, K. J., & Johnson, E. C. (1997) · PubMed · Cited by 392 · see citing works
Peng, X., Gerzanich, V, Anand, R., Whiting, P. J., & Lindstrom, J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09730-5 · Cited by 391 · see citing works
Chronic Exposure to Nicotine Upregulates the Human α4β2 Nicotinic Acetylcholine Receptor Function
Buisson, B., & Bertrand, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01819.2001 · Cited by 361 · see citing works
The paradox of nicotinic acetylcholine receptor upregulation by nicotine
Wonnacott, S. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90242-z · Cited by 357 · see citing works
Volume transmission in the CNS and its relevance for neuropsychopharmacology
Zoli, M. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01343-7 · Cited by 346 · see citing works
Anand, R., Conroy, W. G., Schoepfer, R., Whiting, P. J., & Lindstrom, J. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99147-7 · Cited by 315 · see citing works
Self-citationPartial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit
Papke, R. L., & Heinemann, S. F. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09896-7 · Cited by 259 · see citing works
Gerzanich, V., Wang, F., Kuryatov, A., & Lindstrom, J. M. (1998) · PubMed · Cited by 242 · see citing works
Self-citationKuryatov, A., Gerzanich, V., Nelson, M. E., Olale, F., & Lindstrom, J. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09035.1997 · Cited by 227 · see citing works
Self-citationPicciotto, M. R., Caldarone, B. J., Brunzell, D. H., Zachariou, V., Stevens, T. R., & King, S. L. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00161-9 · Cited by 221 · see citing works
Zwart, R., & Vijverberg, H. P. M. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1124 · Cited by 215 · see citing works
Merlie, J. P., & Lindstrom, J. M. (1983) · Cell · doi:10.1016/0092-8674(83)90531-7 · Cited by 205 · see citing works
Self-citationWhiting, P. J., Schoepfer, R., Lindström, J., & Priestley, T. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15355-8 · Cited by 200 · see citing works
Wang, F., Nelson, M. E., Kuryatov, A., Olale, F., Cooper, J., Keyser, K., & Lindstrom, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28721 · Cited by 187 · see citing works
Self-citationGopalakrishnan, M., Monteggia, L. M., Anderson, D. J., Molinari, E. J., Piattoni-Kaplan, M., Donnelly-Roberts, D., Arneric, S. P., & Sullivan, J. P. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12264-7 · Cited by 178 · see citing works
Whiteaker, P., Sharples, C. G. V., & Wonnacott, S. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13263-4 · Cited by 152 · see citing works
Whiteaker, P., Sharples, C. G., & Wonnacott, S. (1998) · PubMed · doi:10.7270/q2b856pt · Cited by 147 · see citing works
Regulation of alpha4beta2 nicotinic receptor desensitization by calcium and protein kinase C.
Fenster, C. P., Beckman, M. L., Parker, J. C., Sheffield, E. B., Whitworth, T. L., Quick, M. W., & Lester, R. A. J. (1999) · PubMed · Cited by 143 · see citing works
Margiotta, J. F., Berg, D. K., & Dionne, V. E. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.22.8155 · Cited by 130 · see citing works
Gerzanich, V., Wang, F., Kuryatov, A., & Lindstrom, J. M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37589-5 · Cited by 129 · see citing works
Self-citationMarks, M. J., Whiteaker, P., Calcaterra, J., Stitzel, J. A., Bullock, A. E., Grady, S. R., Picciotto, M. R., Changeux, J., & Collins, A. C. (1999) · PubMed · Cited by 126 · see citing works
Neuronal nicotinic acetylcholine receptors: from the gene to the disease
Weiland, S., Bertrand, D., & Leonard, S. S. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00199-6 · Cited by 117 · see citing works
Single channel properties of human α3 AChRs: impact of β2, β4 and α5 subunits
Nelson, M. E., & Lindstrom, J. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0657u.x · Cited by 94 · see citing works
Self-citationRusted, J. M., NEWHOUSE, P. A., & Levin, E. D. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00207-2 · Cited by 93 · see citing works
Regulation of α4β2 Nicotinic Receptor Desensitization by Calcium and Protein Kinase C
Fenster, C. P., Beckman, M. L., Parker, J. C., Sheffield, E. B., Whitworth, T. L., Quick, M. W., & Lester, R. A. J. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12167-0 · Cited by 81 · see citing works
Marks, M. J., Whiteaker, P., Calcaterra, J., Stitzel, J. A., Bullock, A. E., Grady, S. R., Picciotto, M. R., Changeux, J.-P., & Collins, A. C. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38240-0 · Cited by 79 · see citing works
Cooper, S. T., Harkness, P. C., Baker, E. R., & Millar, N. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27145 · Cited by 78 · see citing works
Nelson, M. E., Wang, F., Kuryatov, A., Choi, C. H., Gerzanich, V., & Lindstrom, J. M. (2001) · The Journal of General Physiology · doi:10.1085/jgp.118.5.563 · Cited by 77 · see citing works
Self-citationChavez-Noriega, L. E., Gillespie, A. J., Stauderman, K. A., Crona, J. H., Claeps, B. O., Elliott, K. J., Reid, R. T., Rao, T. S., Veliçelebi, G., Harpold, M. M., et al. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00134-9 · Cited by 73 · see citing works
Ligand Binding and Activation of Rat Nicotinic α4β2 Receptors Stably Expressed in HEK293 Cells
Sabey, K., Paradiso, K. G., Zhang, J., & Steinbach, J. H. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.1.58 · Cited by 66 · see citing works
The unusual nature of epibatidine responses at the α4β2 nicotinic acetylcholine receptor
Buisson, B., Vallejo, Y. F., Green, W. N., & Bertrand, D. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00158-1 · Cited by 45 · see citing works
Acetylcholine receptor extracellular domain determines sensitivity to nicotine-induced inactivation
Kuryatov, A., Olale, F., Choi, C. H., & Lindstrom, J. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00027-3 · Cited by 41 · see citing works
Self-citationButt, C. M., Hutton, S. R., Marks, M. J., & Collins, A. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01135.x · Cited by 23 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mammalian nicotinic acetylcholine receptors: from structure to function
Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009) · Physiological Reviews · doi:10.1152/physrev.00015.2008 · Cited by 1,724 · see citing works
Neuronal nicotinic receptors: from structure to pathology
Gotti, C., & Clementi, F. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.006 · Cited by 970 · see citing works
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882 · see citing works
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
Taly, A., Corringer, P., Guédin, D., Lestage, P. J., & Changeux, J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2927 · Cited by 706 · see citing works
Chromosome 21 and Down syndrome: from genomics to pathophysiology
Antonarakis, S. E., Lyle, R., Dermitzakis, E. T., Reymond, A., & Deutsch, S. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1448 · Cited by 703 · see citing works
Jensen, A. A., Frølund, B., Liljefors, T., & Krogsgaard‐Larsen, P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040219e · Cited by 541 · see citing works
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R. S., Rollema, H., & Bertrand, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 525 · see citing works
Structural and functional diversity of native brain neuronal nicotinic receptors
Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469 · see citing works
Diversity of vertebrate nicotinic acetylcholine receptors
Millar, N. S., & Gotti, C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.041 · Cited by 441 · see citing works
X-ray structure of the human α4β2 nicotinic receptor
Morales-Pérez, C. L., Noviello, C., & Hibbs, R. E. (2016) · Nature · doi:10.1038/nature19785 · Cited by 396 · see citing works
Nicotine binding to brain receptors requires a strong cation–π interaction
Xiu, X., Puskar, N. L., Shanata, J. A. P., Lester, H. A., & Dougherty, D. A. (2009) · Nature · doi:10.1038/nature07768 · Cited by 363 · see citing works
Govind, A. P., Vezina, P., & Green, W. N. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.011 · Cited by 338 · see citing works
Moroni, M., Zwart, R., Sher, E., Cassels, B. K., & Bermúdez, I. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023044 · Cited by 286 · see citing works
Heterogeneity and complexity of native brain nicotinic receptors
Gotti, C., Moretti, M., Gaimarri, A., Zanardi, A., Clementi, F., & Zoli, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.023 · Cited by 282 · see citing works
Diversity of native nicotinic receptor subtypes in mammalian brain
Zoli, M., Pistillo, F., & Gotti, C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.003 · Cited by 277 · see citing works
Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors
Kuryatov, A., Luo, J., Cooper, J., & Lindstrom, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012419 · Cited by 275 · see citing works
Self-citationNicotine upregulates its own receptors through enhanced intracellular maturation
Sallette, J., Pons, S., Devillers-Thiery, A., Soudant, M., Prado de Carvalho, L., Changeux, J.-P., & Corringer, P. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.029 · Cited by 261 · see citing works
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252 · see citing works
Exley, R. A., & Cragg, S. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707510 · Cited by 249 · see citing works
Structural principles of distinct assemblies of the human α4β2 nicotinic receptor
Walsh, R. M., Roh, S., Gharpure, A., Morales-Pérez, C. L., Teng, J., & Hibbs, R. E. (2018) · Nature · doi:10.1038/s41586-018-0081-7 · Cited by 226 · see citing works
Lam, D. C.-L., Girard, L., Ramirez, R. D., Chau, W.-S., Suen, W., Sheridan, S., Tin, V. P., Chung, L., Wong, M. P., Shay, J. W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4628 · Cited by 219 · see citing works
Chronic Nicotine Exposure Upregulates Nicotinic Receptors by a Novel Mechanism
Vallejo, Y. F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5240-04.2005 · Cited by 201 · see citing works
Tapia, L., Kuryatov, A., & Lindstrom, J. M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.030445 · Cited by 196 · see citing works
Self-citationRoles of Accessory Subunits in α4β2* Nicotinic Receptors
Kuryatov, A., Onksen, J., & Lindstrom, J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046789 · Cited by 195 · see citing works
Self-citationα6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease
Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 194 · see citing works
Nashmi, R., Dickinson, M. E., McKinney, S., Jareb, M., Labarca, C., Fraser, S. E., & Lester, H. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-37-11554.2003 · Cited by 188 · see citing works
Merging old and new perspectives on nicotinic acetylcholine receptors
Papke, R. L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.029 · Cited by 183 · see citing works
Levitt, M. D., Abdel-Rehim, M. S., & Furne, J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3525 · Cited by 177 · see citing works
Human α4β2 Acetylcholine Receptors Formed from Linked Subunits
Zhou, Y., Nelson, M. E., Kuryatov, A., Choi, C., Cooper, J., & Lindstrom, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09004.2003 · Cited by 174 · see citing works
Self-citationSrinivasan, R., Pantoja, R., Moss, F. J., Mackey, E. D. W., Son, C. D., Miwa, J., & Lester, H. A. (2011) · Journal of General Physiology · doi:10.1085/jgp.201010532 · Cited by 169 · see citing works
Lester, H. A., Xiao, C., Srinivasan, R., Son, C. D., Miwa, J., Pantoja, R., Banghart, M. R., Dougherty, D. A., Goate, A. M., & Wang, J. C. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9090-7 · Cited by 163 · see citing works
Manipulation of Subunit Stoichiometry in Heteromeric Membrane Proteins
Morales-Pérez, C. L., Noviello, C., & Hibbs, R. E. (2016) · Structure · doi:10.1016/j.str.2016.03.004 · Cited by 150 · see citing works
Nguyen, H. N., Rasmussen, B. A., & Perry, D. C. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056408 · Cited by 148 · see citing works
Assembly and trafficking of nicotinic acetylcholine receptors (Review)
Millar, N. S., & Harkness, P. C. (2008) · Molecular Membrane Biology · doi:10.1080/09687680802035675 · Cited by 142 · see citing works
Unraveling the High- and Low-Sensitivity Agonist Responses of Nicotinic Acetylcholine Receptors
Harpsøe, K., Ahring, P. K., Christensen, J. K., Jensen, M. L., Peters, D., & Balle, T. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1509-11.2011 · Cited by 142 · see citing works
Naturally-expressed nicotinic acetylcholine receptor subtypes
Wu, J., & Lukas, R. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.067 · Cited by 136 · see citing works
Hendrickson, L. M., Guildford, M. J., & Tapper, A. R. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00029 · Cited by 132 · see citing works
Nicotinic acetylcholine receptors and the ascending dopamine pathways
Livingstone, P. D., & Wonnacott, S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.004 · Cited by 131 · see citing works
Neurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 126 · see citing works
Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling
Papke, R. L., & Lindstrom, J. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108021 · Cited by 123 · see citing works
Self-citationCarbone, A., Moroni, M., Groot-Kormelink, P., & Bermúdez, I. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00104.x · Cited by 123 · see citing works
Mazzaferro, S., Benallegue, N., Carbone, A. L., Gasparri, F., Vijayan, R., Biggin, P. C., Moroni, M., & Bermúdez, I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.262014 · Cited by 119 · see citing works
Biogenesis, trafficking and up-regulation of nicotinic ACh receptors
Colombo, S. F., Mazzo, F., Pistillo, F., & Gotti, C. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.023 · Cited by 118 · see citing works
Govind, A. P., Walsh, H., & Green, W. N. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5438-11.2012 · Cited by 116 · see citing works
Neuroimmune Communication in Health and Disease
Reardon, C., Murray, K. M., & Lomax, A. E. (2018) · Physiological Reviews · doi:10.1152/physrev.00035.2017 · Cited by 116 · see citing works
Xiao, C., Nashmi, R., McKinney, S. L., Cai, H., McIntosh, J. M., & Lester, H. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2939-09.2009 · Cited by 115 · see citing works
Nicotinic Receptors in Neurodegeneration
Posadas, I., López‐Hernández, B., & Ceña, V. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030005 · Cited by 113 · see citing works
Zwart, R., Carbone, A. L., Moroni, M., Bermudez, I., Mogg, A. J., Folly, E. A., Broad, L. M., Williams, A. C., Zhang, D., Ding, C., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045104 · Cited by 111 · see citing works
Moffat, C., Pacheco, J. P. G., Sharp, S., Samson, A. J., Bollan, K. A., Huang, J. T.-J., Buckland, S. T., & Connolly, C. N. (2015) · The FASEB Journal · doi:10.1096/fj.14-267179 · Cited by 109 · see citing works
Molecular and Cellular Mechanisms of Action of Nicotine in the CNS
Barik, J., & Wonnacott, S. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_7 · Cited by 108 · see citing works
Nicotine and cannabinoids: parallels, contrasts and interactions
VIVEROS, M., MARCO, E., & FILE, S. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.08.002 · Cited by 106 · see citing works
Linden, D. R., Levitt, M. D., Farrugia, G., & Szurszewski, J. H. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2885 · Cited by 105 · see citing works
Parker, S. L., Fu, Y., McAllen, K., Luo, J., McIntosh, J. M., Lindstrom, J. M., & Sharp, B. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.611 · Cited by 105 · see citing works
Self-citationAllosteric modulation of nicotinic acetylcholine receptors
Chatzidaki, A., & Millar, N. S. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.028 · Cited by 104 · see citing works
Chatterjee, S., Steensland, P., Simms, J. A., Holgate, J. Y., Coe, J. W., Hurst, R. S., Shaffer, C. L., Lowe, J. A., III, Rollema, H., & Bartlett, S. E. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.191 · Cited by 103 · see citing works
Timmermann, D. B., Sandager‐Nielsen, K., Dyhring, T., Smith, M., Jacobsen, A., Nielsen, E., Grunnet, M., Christensen, J., Peters, D., Kohlhaas, K. L., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01989.x · Cited by 103 · see citing works
Stoichiometry of the α9α10 Nicotinic Cholinergic Receptor
Plazas, P. V., Katz, E., Gómez‐Casati, M. E., Bouzat, C., & Elgoyhen, A. B. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3805-05.2005 · Cited by 103 · see citing works
The role of nicotinic acetylcholine receptors in autosomal dominant nocturnal frontal lobe epilepsy
Becchetti, A., Aracri, P., Meneghini, S., Brusco, S., & Amadeo, A. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00022 · Cited by 102 · see citing works
Inside-out neuropharmacology of nicotinic drugs
Henderson, B. J., & Lester, H. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.022 · Cited by 102 · see citing works
Drenan, R. M., Nashmi, R., Imoukhuede, P., Just, H., McKinney, S., & Lester, H. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.039180 · Cited by 100 · see citing works
Khakh, B. S., Fisher, J. A., Nashmi, R., Bowser, D. N., & Lester, H. A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0561-05.2005 · Cited by 100 · see citing works
Nicotine is Highly Effective at Producing Desensitization of Rat α4β2 Neuronal Nicotinic Receptors
Paradiso, K. G., & Steinbach, J. H. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.053447 · Cited by 100 · see citing works
Hans, M., Wilhelm, M., & Swandulla, D. (2012) · Chemical Senses · doi:10.1093/chemse/bjr128 · Cited by 98 · see citing works
Progress in nicotinic receptor structural biology
Gharpure, A., Noviello, C., & Hibbs, R. E. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108086 · Cited by 97 · see citing works
Houchat, J., Cartereau, A., Mauff, A. L., Taillebois, E., & Thany, S. H. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17093222 · Cited by 92 · see citing works
Regulation of neuronal nicotinic receptor traffic and expression
Gaimarri, A., Moretti, M., Riganti, L., Zanardi, A., Clementi, F., & Gotti, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.02.005 · Cited by 89 · see citing works
Li, P., Ann, J., & Akk, G. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22644 · Cited by 88 · see citing works
Corringer, P.-J., Sallette, J., & Changeux, J.-P. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.012 · Cited by 86 · see citing works
Gahring, L. C., Persiyanov, K., Dunn, D. M., Weiss, R. B., Meyer, E. L., & Rogers, S. W. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10943 · Cited by 84 · see citing works
TC‐5214 (S‐(+)‐Mecamylamine): A Neuronal Nicotinic Receptor Modulator with Antidepressant Activity
Lippiello, P. M., Beaver, J. S., Gatto, G. J., James, J. W., Green-Jordan, K., Traina, V. M., Xie, J., & Bencherif, M. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00054.x · Cited by 83 · see citing works
Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors
Wang, J., & Lindstrom, J. M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13745 · Cited by 82 · see citing works
Self-citationMoroni, M., Vijayan, R., Carbone, A. L., Zwart, R., Biggin, P. C., & Bermúdez, I. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1228-08.2008 · Cited by 81 · see citing works
Marks, M. J., Rowell, P. P., Cao, J., Grady, S. R., McCallum, S. E., & Collins, A. C. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.009 · Cited by 81 · see citing works
Sallette, J., Bohler, S., Benoit, P., Soudant, M., Pons, S., Le Novère, N., Changeux, J.-P., & Corringer, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308260200 · Cited by 80 · see citing works
Transcription Deregulation at the 15q25 Locus in Association with Lung Adenocarcinoma Risk
Falvella, F. S., Galvan, A., Frullanti, E., Spinola, M., Calabrò, E., Carbone, A., Incarbone, M., Santambrogio, L., Pastorino, U., & Dragani, T. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2107 · Cited by 80 · see citing works
Papke, R. L., Dwoskin, L. P., Crooks, P. A., Zheng, G., Zhang, Z., McIntosh, J. M., & Stokes, C. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.03.010 · Cited by 79 · see citing works
Henderson, B. J., Wall, T. R., Henley, B. M., Kim, C. H., Nichols, W. A., Moaddel, R., Xiao, C., & Lester, H. A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4194-15.2016 · Cited by 79 · see citing works
Functional alterations by a subgroup of neonicotinoid pesticides in human dopaminergic neurons
Loser, D., Hinojosa, M. G., Blum, J. H., Schaefer, J., Brüll, M., Johansson, Y., Suciu, I., Grillberger, K., Danker, T., Möller, C., et al. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03031-1 · Cited by 75 · see citing works
Molgó, J., Marchot, P., Aráoz, R., Benoit, É., Iorga, B. I., Zakarian, A., Taylor, P., Bourne, Y., & Servent, D. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13995 · Cited by 75 · see citing works
Huang, L. Z., Campos, C., Ly, J., Carroll, F. I., & Quik, M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.032 · Cited by 73 · see citing works
Coe, J. W., Brooks, P. R., Wirtz, M. C., Bashore, C. G., Bianco, K. E., Vetelino, M. G., Arnold, E. P., Lebel, L. A., Fox, C. B., Tingley, F. D., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.08.035 · Cited by 73 · see citing works
Barrera, N. P., Betts, J. F., You, H., Henderson, R. M., Martin, I. L., Dunn, S. M. J., & Edwardson, J. M. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.042481 · Cited by 72 · see citing works
Grishin, A. A., Wang, C.-I. A., Muttenthaler, M., Alewood, P. F., Lewis, R. J., & Adams, D. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.111880 · Cited by 71 · see citing works
Gotti, C., Moretti, M., Zanardi, A., Gaimarri, A., Champtiaux, N., Changeux, J., Whiteaker, P., Marks, M. J., Clementi, F., & Zoli, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015925 · Cited by 71 · see citing works
Tsuneki, H., You, Y., Toyooka, N., Kagawa, S., Kobayashi, S., Sasaoka, T., Nemoto, H., Kimura, I., & Dani, J. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000729 · Cited by 70 · see citing works
Lamb, P. W., Melton, M. A., & Yakel, J. L. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:1:013 · Cited by 70 · see citing works
Billen, B., Spurný, R., Brams, M., van Elk, R., Valera-Kummer, S., Yakel, J. L., Voets, T., Bertrand, D., Smit, A. B., & Ulens, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116397109 · Cited by 69 · see citing works
Coe, J. W., Vetelino, M. G., Bashore, C. G., Wirtz, M. C., Brooks, P. R., Arnold, E. P., Lebel, L. A., Fox, C. B., Sands, S. B., Davis, T. I., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.04.036 · Cited by 69 · see citing works
Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning
Gould, T. J., & Leach, P. T. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.08.004 · Cited by 68 · see citing works
3B but which 3B? And that's just one of the questions: the heterogeneity of human 5-HT3 receptors
Jensen, A. A., Davies, P. A., Bräuner‐Osborne, H., & Krzywkowski, K. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.06.001 · Cited by 68 · see citing works
Live-Cell Imaging of Single Receptor Composition Using Zero-Mode Waveguide Nanostructures
Richards, C. I., Luong, K., Srinivasan, R., Turner, S. W., Dougherty, D. A., Korlach, J., & Lester, H. A. (2012) · Nano Letters · doi:10.1021/nl301480h · Cited by 68 · see citing works
Gotti, C., Moretti, M., Meinerz, N. M., Clementi, F., Gaimarri, A., Collins, A. C., & Marks, M. J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045203 · Cited by 68 · see citing works
Gao, B.-X., Hierl, M., Clarkin, K., Juan, T., Nguyen, H. Q., van der Valk, M., Deng, H. X., Guo, W., Lehto, S. G., Matson, D. J., et al. (2010) · Pain · doi:10.1016/j.pain.2010.01.007 · Cited by 67 · see citing works
Papke, R. L., Wecker, L., & Stitzel, J. A. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.164566 · Cited by 67 · see citing works
Krashia, P., Moroni, M., Broadbent, S. D., Hofmann, G., Kracun, S., Beato, M., Groot‐Kormelink, P. J., & Sivilotti, L. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013611 · Cited by 66 · see citing works
Nicotine addiction and psychiatric disorders
Kutlu, M. G., Parikh, V., & Gould, T. J. (2015) · International Review of Neurobiology · doi:10.1016/bs.irn.2015.08.004 · Cited by 65 · see citing works
Kouvatsos, N., Giastas, P., Chroni-Tzartou, D., Poulopoulou, C., & Tzartos, S. J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602619113 · Cited by 65 · see citing works
Cognitive Deficits in Schizophrenia: Focus on Neuronal Nicotinic Acetylcholine Receptors and Smoking
Ochoa, E. L. M., & Lasalde‐Dominicci, J. A. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9149-x · Cited by 64 · see citing works
Stoichiometry and Pharmacology of Two Human α4β2 Nicotinic Receptor Types
Moroni, M., & Bermúdez, I. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:30:1:95 · Cited by 62 · see citing works
Structural determinants of α4β2 nicotinic acetylcholine receptor trafficking
Ren, X.-Q., Cheng, S.-B., Treuil, M. W., Mukherjee, J., Rao, J., Braunewell, K. H., Lindstrom, J. M., & Anand, R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1079-05.2005 · Cited by 61 · see citing works
Self-citation
- Authors
- Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., & Lindstrom, J.
- Affiliations
- University of Pennsylvania (US)
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2003-02
- Volume
- 63
- Issue
- 2
- Pages
- 332-341
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2337946333
- Semantic Scholar
- dbb214d9298a2934b4b744d775aff014dcfae0be
- Cited by
- 422
- References
- 45
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 9 · 2023: 8 · 2022: 10 · 2021: 14 · 2020: 18 · 2019: 8 · 2018: 10 · 2017: 16 · 2016: 23 · 2015: 29 · 2014: 28 · 2013: 23 · 2012: 31
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS011323)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- nicotinic acetylcholine receptors, subunit stoichiometry, acetylcholine sensitivity, nicotine, receptor maturation, transient transfection, temperature effects, human embryonic kidney cells
- MeSH terms
- Cells, Cultured, Humans, Receptors, Nicotinic, Temperature, Transfection, DNA, Complementary, Cholinergic Agonists, Protein Subunits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review